Generic Injectable Market to Undertake Strapping Growth Generic Injectable Market | Page 4

Generic Injectable Market Analysis
Generic Injectable Market to Expand with Significant CAGR During 2019-2029
Currently at a nascent stage, the global generic injectable market is projected to witness exponential growth in
sales at around 12% CAGR during 2019 - 2029. Over the course of forecast period, generic injectable sales will
experience 3X growth, as indicated by a new Future Market Insights (FMI) study. Increasing patient preference
for self-administration of drugs is primarily developing a fertile ground for the generic injectable market, says
the report.
"The generic pharmaceuticals sector is gaining a boost from frequent FDA approvals. Launch of low-cost
injectables through investments in consolidations and mergers has been a major highlight," states the FMI
report.
Key Takeaways: Generic Injectable Market
• Demand for monoclonal antibodies (mAbs) would remain significant; vaccines are gaining traction.
• Generic injectable market continues to see emergence of high-value opportunities in North America and
Europe.
• Asian markets would capture investors' attention, owing to solid growth in pharma production capacities and
technology penetration.
• High preference for small molecule drugs will prevail
www.futuremarketinsights.com I
@futuremarketins I
/company/future-market-insights
© 2019 Future Market Insights, All Rights Reserved
4